About APT...
APT Pharmaceuticals is focused on the development of cyclosporine inhalation solution (CIS) for the prevention of chronic rejection in lung transplantation.
Lung Transplantation
Chronic rejection is irreversible and is the major driver of poor long term outcomes in lung transplantation.